Scarica l'app Stockscreener
2.58
16.23%
-0.50
Dopo l'orario di chiusura:
2.32
-0.26
-10.08%
Precedente Chiudi:
$3.08
Aprire:
$2.82
Volume 24 ore:
1.03M
Relative Volume:
0.80
Capitalizzazione di mercato:
$7.32M
Reddito:
-
Utile/perdita netta:
$-11.27M
Rapporto P/E:
-0.1205
EPS:
-21.4132
Flusso di cassa netto:
$-9.40M
1 W Prestazione:
+18.89%
1M Prestazione:
+38.71%
6M Prestazione:
-63.10%
1 anno Prestazione:
-78.14%
Intervallo 1D:
$2.49
$2.9982
Intervallo di 1 settimana:
$2.01
$4.66
Portata 52W:
$1.58
$23.70
Dermata Therapeutics Inc Stock (DRMA) Company Profile
Nome
Dermata Therapeutics Inc
Settore
Industria
Telefono
(858)-223-0882
Indirizzo
3525 DEL MAR HEIGHTS RD., #322, SAN DIEGO
Confronta DRMA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DRMA
Dermata Therapeutics Inc
|
2.58 | 8.73M | 0 | -11.27M | -9.40M | -21.41 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.17 | 120.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
771.25 | 80.15B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
864.42 | 51.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
354.75 | 47.74B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
336.16 | 37.38B | 4.98B | 69.59M | 525.67M | 0.5197 |
Dermata Therapeutics Inc Borsa (DRMA) Ultime notizie
Meme Stocks: Is NRx Pharmaceuticals Inc Equity Warrant forming a breakout pattern2025 Market Overview & Expert Curated Trade Setups - baoquankhu1.vn
Dermata Therapeutics increases at-the-market offering by $705,000 By Investing.com - Investing.com South Africa
Dermata Therapeutics increases at-the-market offering by $705,000 - Investing.com South Africa
Dermata Therapeutics Expands At-The-Market Equity Offering Capacity - TipRanks
Market Movers | Winners: GRI, XXII, LRHC | Losers: NBY, EMAT, APUS - Trefis
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Gap Down: Why is AHLPRF stock going downMarket Activity Report & Accurate Intraday Trade Tips - baoquankhu1.vn
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Whats next for M3 Brigade Acquisition V Corp stockJuly 2025 Spike Watch & Precise Buy Zone Identification - baoquankhu1.vn
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Aug Momentum: Does RRGB meet Warren Buffetts criteriaMarket Trend Summary & Precise Swing Trade Alerts - baoquankhu1.vn
Dermata receives Australian patent for Spongilla acne treatment By Investing.com - Investing.com Nigeria
Dermata receives Australian patent for Spongilla acne treatment - Investing.com
Dermata Receives Notice of Grant of Patent for Next-Generation Acne Treatment by Australian Patent Office - ACCESS Newswire
3.3M Australians with acne: Dermata's new treatment patent - Stock Titan
Will Dermata Therapeutics Inc. stock outperform growth indexesJuly 2025 Reactions & Stock Market Timing Techniques - bollywoodhelpline.com
Fundamentals Check: Will Dermata Therapeutics Inc benefit from seasonalityTrade Analysis Report & AI Driven Price Predictions - baoquankhu1.vn
Can Grace Therapeutics Inc. weather a recessionRate Cut & Safe Capital Growth Trade Ideas - bollywoodhelpline.com
How buybacks impact Dermata Therapeutics Inc. stock value2025 Trade Ideas & Verified Stock Trade Ideas - ulpravda.ru
Can Dermata Therapeutics Inc. Equity Warrant stock deliver consistent earnings growthQuarterly Profit Report & AI Based Trade Execution Alerts - ulpravda.ru
Axillary Hyperhidrosis Market to Evolve Rapidly Over the Next Decade by 2034, DelveInsight Observes | Botanix Pharma, Sound Surgical Tech, Dr. August Wolff GmbH, Medy-Tox, Journey Medical Corp. - Barchart.com
Will Dermata Therapeutics Inc. stock attract more institutional investorsFit and Size Notes & support options for steady strides - Улправда
Dermata Therapeutics Inc. (DRMA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
What dividend safety score for Dermata Therapeutics Inc. Equity Warrant stockJuly 2025 Big Picture & Daily Profit Focused Screening - Улправда
Is Dermata Therapeutics Inc. stock a top pick in earnings seasonMarket Movers & Free Expert Verified Stock Movement Alerts - Улправда
Why Dermata Therapeutics Inc. Equity Warrant stock is popular among millennialsTrade Exit Summary & Smart Investment Allocation Insights - Улправда
Is Dermata Therapeutics Inc. stock a contrarian buyJuly 2025 Catalysts & Safe Entry Zone Tips - ulpravda.ru
Is Dermata Therapeutics Inc. stock trading at a premium valuationJuly 2025 Setups & Safe Entry Trade Signal Reports - ulpravda.ru
Aug Ideas: How Dermata Therapeutics Inc. Equity Warrant stock reacts to oil pricesGap Up & Scalable Portfolio Growth Methods - ulpravda.ru
Why Dermata Therapeutics Inc. Equity Warrant stock is a value investor pick2025 Market Trends & Community Consensus Trade Signals - Улправда
How Dermata Therapeutics Inc. stock benefits from global expansion2025 Biggest Moves & Technical Entry and Exit Tips - Улправда
Dermata Therapeutics Inc Equity Warrant Stock Analysis and ForecastBullish Engulfing Patterns & Free Phenomenal Capital Appreciation - earlytimes.in
Pre-market Movers: RSLS, STSS, VERO, KTTA... - RTTNews
Dermata Therapeutics announces $2.55M private offering - MSN
Top 5 stocks to watch today | December 30th - MSN
Dermata Therapeutics: Is Change on the Horizon? - StocksToTrade
Dermata Therapeutics: Unveiling Bold Moves - timothysykes.com
Top 5 Stocks To Watch Today | December 30th - MSN
Stock Market Today: S&P 500, Dow Jones Futures Trade Mixed Amid Blip In Santa Claus Rally—Boeing, Freeport-McMoRan, Fonar In Focus - Benzinga
Verastem, TEN Holdings And 3 Stocks To Watch Heading Into Tuesday - Benzinga
Dermata stock surges after closing $4.1 million private placement By Investing.com - Investing.com Australia
Dermata stock surges after closing $4.1 million private placement - Investing.com
Dermata Therapeutics Signs Multiple Material Agreements - TradingView — Track All Markets
Dermata Therapeutics Announces Closing of up to $12.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules - Weatherford Democrat
Skincare firm Dermata raises $4.1M to back new over-the-counter acne kit - Stock Titan
Crown Labs completes acquisition of Revance Therapeutics - MSN
Bank Watch: Why Dermata Therapeutics Inc Equity Warrant stock is popular among millennialsQuarterly Profit Report & High Accuracy Investment Entry Signals - moha.gov.vn
Dermata Therapeutics Announces up to $12.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules - Fox21Online
Dermata Therapeutics, Inc.Warrant (NQ: DRMAW - FinancialContent
Dermata Therapeutics’ Skincare Innovation Sparks Interest - StocksToTrade
Dermata Therapeutics, Inc. (DRMA) Stock: Surges 25% as Insider-Backed $4.1M Offering Fuels Momentum - parameter.io
Dermata Therapeutics Inc Azioni (DRMA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.09%
0.48%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):